• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    Navidea Biopharmaceuticals, Inc (NAVB)

    -NYSE MKT
    1.67 Down 0.03(1.76%) 4:00PM EST
    Add to Portfolio
    Prev Close:1.70
    Open:1.72
    Bid:1.66 x 8500
    Ask:1.67 x 1700
    1y Target Est:4.56
    Beta:1.12
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:1.66 - 1.75
    52wk Range:0.97 - 2.12
    Volume:731,652
    Avg Vol (3m):1,022,700
    Market Cap:250.79M
    P/E (ttm):N/A
    EPS (ttm):-0.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NAVB

    Comparison

    Symbol% ChgMkt Cap
    NAVBDown 1.76%250.79M
    LLYDown 3.09%72.56B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):55.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.79
    Quarterly EPS Est (Mar-15) :-0.03
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback